Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 20/20 | 0.68 |
| ▸ | BIRC3 | Q13489 | 10/20 | 0.68 |
| ▸ | BIRC2 | Q13490 | 4/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12934264 | 0.93 | XIAP (0.69) | XIAPBIRC3BIRC2 | |
| SCHEMBL1273401 | 0.92 | XIAP (0.68) | XIAPBIRC3BIRC2 | |
| SCHEMBL10066036 | 0.90 | XIAP (0.60) | XIAPBIRC3BIRC2 | |
| SCHEMBL12932687 | 0.89 | XIAP (0.64) | XIAPBIRC3BIRC2 | |
| SCHEMBL12933466 | 0.89 | XIAP (0.63) | XIAPBIRC3BIRC2 | |
| SCHEMBL12130821 | 0.88 | XIAP (0.61) | XIAPBIRC3BIRC2 | |
| SCHEMBL12134109 | 0.88 | XIAP (0.61) | XIAPBIRC3BIRC2 | |
| SCHEMBL12932686 | 0.88 | XIAP (0.66) | XIAPBIRC3BIRC2 | |
| SCHEMBL13872920 | 0.87 | XIAP (0.59) | XIAPBIRC3BIRC2 | |
| SCHEMBL12933442 | 0.86 | XIAP (0.64) | XIAPBIRC3BIRC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110034469-A1 | Heterocyclic Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-02-10 | — | — | US | disclosed |
| US-20110034469-A1 | Heterocyclic Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034469-A1 | Heterocyclic Compound | BIRC5, XIAP, BIRC2 | XIAP 2/4885BIRC3 7/4885BIRC2 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.